Clinical trial
Safety and Efficacy of AGN201781 in Neuropathic Pain
NCT00533351 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of AGN201781 in Neuropathic Pain
- Lead sponsor
- Allergan
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- March 31, 2008
- Completion date
- June 30, 2008
- Enrollment
- 9 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.